ShockWave Medical prices upsized IPO above the range at $17

Shutterstock photo

ShockWave Medical, which sells medical systems used in treating cardiovascular disease, raised $97 million by offering 5.7 million shares at $17. The company had originally planned to offer 5.0 million shares at a range of $14 to $16. Additionally, insider Abiomed agreed to invest $10 million in a concurrent private placement.

ShockWave Medical plans to list on the Nasdaq under the symbol SWAV. Morgan Stanley and BofA Merrill Lynch acted as lead managers on the deal.

The article ShockWave Medical prices upsized IPO above the range at $17 originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?